NCT01907074View on ClinicalTrials.gov

Quantitative Liver Function Tests Using Cholates

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
End Stage Liver Disease
Interventions
DRUG

Cholates

Cholates is given intravenously (IV push) and by mouth, once per study visit

Trial Locations (1)

75246

Baylor University Medical Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER

NCT01907074 - Quantitative Liver Function Tests Using Cholates | Biotech Hunter | Biotech Hunter